CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 20,000 shares worth $765,309
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 17 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 20,000 shares at a cost of $38.27. At the time of this transaction (Jun 15), this trade was worth $765,309 in total. As of Jun 15, Robins Chad M now owns 1,728,461 shares in total worth about $68,827,317.02.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) CEO and Chairman, Robins Chad M, we have the following information:
- SEC Form 4 filing: Jun 16: Sold 4,745 shares at the rate of $38.13 per share. Total worth of this trade was $180,927. Total number of shares owned as of Jun 16 were 1,723,716
- SEC Form 4 filing: Jun 17: Sold 5,255 shares at the rate of $39.53 per share. Total worth of this trade was $207,729. Total number of shares owned as of Jun 17 were 1,718,461
- SEC Form 4 filing: Apr 06: Sold 5,000 shares at the rate of $42.18 per share. Total worth of this trade was $210,880. Total number of shares owned as of Apr 06 were 1,758,461
Posted by
George Daniels
on Friday June 18 2021, 1:59 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
